Follow the Orchid Pharma Limited share price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Orchid Pharma Limited has recorded 4 insider filings. Market capitalisation: €50bn. The latest transaction was filed on 24 January 2022 (Pledge). Among the most active insiders: M/s Dhanuka Laboratories Limited. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Orchid Pharma Limited is a company focused on the health and pharmaceutical sector, providing innovative pharmaceutical solutions. It is listed on the XBOM market.